{
 "name": "全福生技",
 "slug": "tw-6885",
 "aliases": [
  "全福生物科技股份有限公司",
  "BRIM",
  "6885"
 ],
 "ticker": "6885",
 "industry": "生技醫療業",
 "website": "https://www.brimbiotech.com/",
 "summary": "全福生技（6885）是上市的生技醫療類股公司，2013 年成立，2024 年上市。基本資料取自臺灣證券交易所／證券櫃檯買賣中心公開資料；重大訊息見 https://drugnews.com.tw/filings/ 。",
 "facts": [
  {
   "claim": "公司全名",
   "value": "全福生物科技股份有限公司",
   "unit": "",
   "as_of": "2026-10-21",
   "source": "https://openapi.twse.com.tw/v1/opendata/t187ap03_L"
  },
  {
   "claim": "英文簡稱",
   "value": "BRIM",
   "unit": "",
   "as_of": "2026-10-21",
   "source": "https://openapi.twse.com.tw/v1/opendata/t187ap03_L"
  },
  {
   "claim": "產業類別",
   "value": "生技醫療業",
   "unit": "",
   "as_of": "2026-10-21",
   "source": "https://openapi.twse.com.tw/v1/opendata/t187ap03_L"
  },
  {
   "claim": "掛牌市場",
   "value": "臺灣證券交易所上市",
   "unit": "",
   "as_of": "2026-10-21",
   "source": "https://openapi.twse.com.tw/v1/opendata/t187ap03_L"
  },
  {
   "claim": "上市日期",
   "value": "2024-12-16",
   "unit": "",
   "as_of": "2026-10-21",
   "source": "https://openapi.twse.com.tw/v1/opendata/t187ap03_L"
  },
  {
   "claim": "成立日期",
   "value": "2013-07-31",
   "unit": "",
   "as_of": "2026-10-21",
   "source": "https://openapi.twse.com.tw/v1/opendata/t187ap03_L"
  },
  {
   "claim": "董事長",
   "value": "林羣",
   "unit": "",
   "as_of": "2026-10-21",
   "source": "https://openapi.twse.com.tw/v1/opendata/t187ap03_L"
  },
  {
   "claim": "總經理",
   "value": "徐文祺",
   "unit": "",
   "as_of": "2026-10-21",
   "source": "https://openapi.twse.com.tw/v1/opendata/t187ap03_L"
  },
  {
   "claim": "實收資本額",
   "value": 1330990000,
   "unit": "新台幣元",
   "as_of": "2026-10-21",
   "source": "https://openapi.twse.com.tw/v1/opendata/t187ap03_L"
  },
  {
   "claim": "簽證會計師事務所",
   "value": "資誠聯合會計師事務所",
   "unit": "",
   "as_of": "2026-10-21",
   "source": "https://openapi.twse.com.tw/v1/opendata/t187ap03_L"
  },
  {
   "claim": "公司網址",
   "value": "https://www.brimbiotech.com/",
   "unit": "",
   "as_of": "2026-10-21",
   "source": "https://openapi.twse.com.tw/v1/opendata/t187ap03_L"
  },
  {
   "claim": "月營收（2026-09）",
   "value": 1232,
   "unit": "新台幣千元",
   "as_of": "2026-10-17",
   "source": "https://openapi.twse.com.tw/v1/opendata/t187ap05_L",
   "note": "原檔二手來源不符合本次白名單；回查官方115年09月營收申報，claim/value/unit/as_of保留，僅更正輸出複本source。核對列與原來源保存在research/basic_source_corrections.json。"
  },
  {
   "claim": "月營收年增率（2026-09）",
   "value": 209.55,
   "unit": "%",
   "as_of": "2026-10-17",
   "source": "https://openapi.twse.com.tw/v1/opendata/t187ap05_L",
   "note": "原檔二手來源不符合本次白名單；回查官方115年09月營收申報，claim/value/unit/as_of保留，僅更正輸出複本source。核對列與原來源保存在research/basic_source_corrections.json。"
  },
  {
   "claim": "累計營收年增率（2026 年 1 月至 09 月）",
   "value": 242.96,
   "unit": "%",
   "as_of": "2026-10-17",
   "source": "https://openapi.twse.com.tw/v1/opendata/t187ap05_L",
   "note": "原檔二手來源不符合本次白名單；回查官方115年09月營收申報，claim/value/unit/as_of保留，僅更正輸出複本source。核對列與原來源保存在research/basic_source_corrections.json。"
  },
  {
   "claim": "管線：BRM421",
   "value": "乾眼症｜第II期劑量探索臨床收案中｜台灣",
   "unit": "",
   "as_of": "2026-08-25",
   "source": "https://www.brimbiotech.com/archives/16671",
   "note": " 試驗登錄：NCT07078955 https://clinicaltrials.gov/study/NCT07078955 。"
  },
  {
   "claim": "管線：BRM424",
   "value": "神經營養性角膜炎｜第II期初步結果已公告、規劃下一階段臨床｜美國、巴西",
   "unit": "",
   "as_of": "2026-09-21",
   "source": "https://mopsov.twse.com.tw/mops/web/ajax_t05st01?firstin=1&step=2&seq_no=1&spoke_time=31151&spoke_date=20260921&co_id=6885&TYPEK=sii",
   "note": "發言日期：115/09/21；主旨：公告本公司開發中新藥BRM424治療神經營養性角膜炎 第II期人體臨床試驗初步結果(Topline Results)。。NCT05927428；試驗地區補充依公司2026-08-25新聞稿 https://www.brimbiotech.com/archives/16671 。開放標籤劑量探索，無平行對照組。"
  },
  {
   "claim": "管線：BRM411（TO-O-1001）",
   "value": "青光眼｜第II期臨床收案中｜台灣",
   "unit": "",
   "as_of": "2026-08-25",
   "source": "https://www.brimbiotech.com/archives/16671",
   "note": "TO-O-1001別名依2025年度年報PDF第107頁。"
  },
  {
   "claim": "管線：BRM412（TO-O-1002）",
   "value": "濕式黃斑部病變｜新配方改良、第II期臨床規劃中｜地區未揭露",
   "unit": "",
   "as_of": "2026-05-11",
   "source": "https://www.brimbiotech.com/wp-content/uploads/ir_annual_2025.pdf",
   "note": "既有配方曾完成泰國IIa期；新配方試驗地區未揭露，不混用前後階段。"
  },
  {
   "claim": "管線：BRM521",
   "value": "退化性關節炎｜藥物優化及動物模型驗證｜地區未揭露",
   "unit": "",
   "as_of": "2026-05-11",
   "source": "https://www.brimbiotech.com/wp-content/uploads/ir_annual_2025.pdf"
  },
  {
   "claim": "管線：BRM421（角膜緣幹細胞缺乏症）",
   "value": "角膜緣幹細胞缺乏症｜Expanded Access擴大取得計畫、AVAILABLE、未列Phase｜美國",
   "unit": "",
   "as_of": "2026-02-20",
   "source": "https://clinicaltrials.gov/study/NCT07422389",
   "note": "NCT07422389；擴大取得計畫，非新增已分期註冊試驗或上市核准。"
  },
  {
   "claim": "催化劑：BRM421（乾眼症劑量探索）",
   "value": "主要完成（試驗登錄預估）｜2026-11｜已公告",
   "unit": "",
   "as_of": "2025-10-20",
   "source": "https://clinicaltrials.gov/study/NCT07078955",
   "note": "NCT07078955；primaryCompletionDateStruct.type=ESTIMATED；最後登錄更新2025-10-20，後續2026-08公司稿稱收案中，未將預估當結果。"
  },
  {
   "claim": "催化劑：BRM421（乾眼症劑量探索）",
   "value": "試驗完成（試驗登錄預估）｜2027-03｜已公告",
   "unit": "",
   "as_of": "2025-10-20",
   "source": "https://clinicaltrials.gov/study/NCT07078955",
   "note": "NCT07078955；completionDateStruct.type=ESTIMATED；未自月份補出日期。"
  }
 ],
 "responses": [],
 "provided_by": "public_sources",
 "verified_by": "Drugnews｜藥時事",
 "verified_at": "2026-10-22",
 "disclosure": "Drugnews 依公開來源（公司公告、公開資訊觀測站、試驗登錄、主管機關文件）整理，於 verified_at 逐條核對來源；未經公司審閱。",
 "url": "https://drugnews.com.tw/companies/tw-6885.json",
 "generated_at": "2026-10-23T01:06:05.573Z"
}